Harnessing CRISPR-Cas to Combat COVID-19: From Diagnostics to Therapeutics
The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global threat with an ever-increasing death toll even after a year on. Hence, the rapid identification of infected individuals with diagnostic tests continues to be crucial in t...
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
MDPI AG
2021-11-01
|
| Saila: | Life |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.mdpi.com/2075-1729/11/11/1210 |
Search Result 1
Harnessing CRISPR-Cas to combat COVID-19: from diagnostics to therapeutics
Argitaratua 2021
Testu osoa
Artikulua